Paydirt
RLMD
Ticker

Relmada Therapeutics, Inc.

RLMD · Healthcare · Relmada Therapeutics, Inc. operates as a clinical-stage biotechnology company in the United States

Relmada Therapeutics, Inc. (RLMD), in the Healthcare sector, has 7 disclosed filings on Paydirt over the trailing twelve months from 4 corporate insiders: 7 purchases and 0 sales. Filers took a median of 1 day from execution to disclosure, and the most recent trade was executed Sep 10 and filed Sep 11. The most active filer was Sergio Traversa with 3 filings.

Add to watchlist
Filings, ttm
7
7 buys · 0 sells
Traders, ttm
4
4 insiders
Volume, ttmiDollar value disclosed in the window
$4.0M
estimated for Congress, as filed for insiders
Median delay
1d
execution to disclosure
Last traded
Sep 10
Filed Sep 11
ADViAverage daily dollar volume
$7.1M
market data
Share price · 12M
$4.20 (+154.5%)
$7.86$4.76$1.65Sep 22 2025Mar 20Sep 17

Adjusted for splits and dividends.

Volume by month
$2.2M$1.1M$0Oct 2024Apr 2025Oct 2025Apr 2026May 2025 · buys $103KNov 2025 · buys $2.2MDec 2025 · buys $113KSep 2026 · buys $1.7M
Buys $4.1M Sells $0

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed
ST Sergio Traversa Chief Executive Officer 3 filings CE Chuck Ence CAO and COO 2 filings MS Maged Shenouda Chief Financial Officer 2 filings PK Paul Edward Kelly Chief Operating Officer 1 filing
Recent filings
Maged ShenoudaPURCHASE Chief Financial Officer $844K
200,000 sh across 2 lots
Exec Sep 9
Filed Sep 11 · 7:30 AM ET Sergio TraversaPURCHASE Chief Executive Officer $828K
200,000 sh across 2 lots
Exec Sep 9
Filed Sep 11 · 7:30 AM ET Sergio TraversaPURCHASE Chief Executive Officer $113K
27,500 sh × $4.12
Exec Dec 15 2025
Filed Dec 16 2025 · 9:30 AM ET Maged ShenoudaPURCHASE Chief Financial Officer $1.1M
500,000 sh × $2.20
Exec Nov 5 2025
Filed Nov 6 2025 · 7:30 AM ET Chuck EncePURCHASE CAO and COO $299K
136,000 sh × $2.20
Exec Nov 5 2025
Filed Nov 6 2025 · 7:30 AM ET Sergio TraversaPURCHASE Chief Executive Officer $600K
272,500 sh × $2.20
Exec Nov 5 2025
Filed Nov 6 2025 · 7:30 AM ET Paul Edward KellyPURCHASE Chief Operating Officer $198K
90,000 sh × $2.20
Exec Nov 5 2025
Filed Nov 6 2025 · 7:30 AM ET Chuck EncePURCHASE CA and CO $103K
228,961 sh × $0.45
Exec May 16 2025
Filed May 20 2025 · 5:30 PM ET Sergio TraversaPURCHASE Chief Executive Officer $304K
106,986 sh across 2 lots
Exec Sep 9 2024
Filed Sep 11 2024 · 5:30 PM ET